MedTrace Logo

Methoxyflurane for Analgesia During Hysteroscopy

NCT06899724 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2025-03-28

No results posted yet for this study

Summary

This study is to assess the non-inferiority of using inhaled methoxyflurane (MOF) versus intravenous conscious sedation with fentanyl and midazolam on women's perception of pain, during hysteroscopy and/or polypectomy in an outpatient setting. The researchers will determine whether the participants receiving the inhaled MOF (experimental group) achieve similar clinical effects in reduction of pain and ability to complete the procedure. Women's perception of pain will be recorded on a scale from 0 to 10 using the numeric rating scale (NRS).

Conditions

  • Analgesia

Interventions

DRUG

Anesthetics, Inhalation

Inhaled analgesia

DRUG

Intravenous Sedatives with or Without Analgesia

IV Fentanyl and midazolam

Sponsors & Collaborators

  • Dr. John A. Thiel Medical Professional Corporation

    lead OTHER

Principal Investigators

  • Peter S Thiel, MD MPH FRCSC · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-12-31
Completion
2026-01-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06899724 on ClinicalTrials.gov